Foley RN, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16:489–495. doi: 10.1681/ASN.2004030203
Arinze NV, et al. Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease. J Clin Invest 2022; 132:e142260. doi: 10.1172/JCI142260
Shashar M, et al. Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk. Sci Transl Med 2017; 9:eaam8475. doi: 10.1126/scitranslmed.aam8475
Campesato LF, et al. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-kynurenine. Nat Commun 2020; 11:4011. doi: 10.1038/s41467-020-17750-z